Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Upcoming letter to shareholders Billwilke
2
Aug 12, 2008 09:07PM

"Now I'd like to find out if the head to head meeting witht the PTO examiner has taken place. I have to believe that Charles Moore walks away from that meeting with a good read on the examiners mindset (yea or nay)."

Billwilke I thought we had established last week that a meeting had taken place.

I agree with you that in a face to face meeting, Moore/TPL comes away from the meeting with a very good idea of the outcome imo. Also one would think that the face to face meeting would speed up the process imo.

I've got my fingers crossed as well.

Alll the best,

Steve

Share
New Message
Please login to post a reply